Clinicopathological and prognostic significance of EGFR over-expression in esophageal squamous cell carcinoma: A meta-analysis

Hepato-Gastroenterology

Volumn 58, Issue 106, 2011, Pages 426-431

  Yu, Wei Wei ^a   Guo, Yan Mei ^b   Zhu, Min ^b   Cai, Xu Wei ^a   Zhu, Zheng Fei ^a   Zhao, Wei Xin ^a   Fu, Xiao Long ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Epidermal growth factor receptor; Esophageal squamous cell carcinoma; Meta analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TISSUE DIFFERENTIATION;

CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVALS; ESOPHAGEAL NEOPLASMS; HUMANS; ODDS RATIO; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 79958123433     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. Cancer J Clin 2005; 55:74-108.
2. Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med 2003; 349:2241-2252. (Pubitemid 37485141)
3. Guo A, Villen J, Kornhauser J, Lee KA, Stokes MP, Rikova K, Possemato A, Nardone J, Innocenti G, Wetzel R, Wang Y, MacNeill J, Mitchell J, Gygi SP, Rush J, Polakiewicz RD, Comb MJ: Signaling networks assembled by oncogenic EGFR and c-Met. P Natl Acad Sci USA 2008; 105:692-697. (Pubitemid 351171770)
4. Grandis JR, Sok JC: Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 2004; 102:37-46. (Pubitemid 38429984)
5. Yarden Y, Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Bio 2001; 2:127-137. (Pubitemid 33674041)
6. Kimura M, Tsuda H, Morita D, Ichikura T, Ogata S, Aida S, Yoshizumi Y, Maehara T, Mochizuki H, Matsubara O: A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements. Virchows Arch 2004; 445:255-262. (Pubitemid 39286893)
7. Ooi A, Takehana T, Li X, Suzuki S, Kunitomo K, Iino H, Fujii H, Takeda Y, Dobashi Y: Protein over-expression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study. Mod Pathol 2004; 17:895-904. (Pubitemid 38993773)
8. DiGiovanna MP, Stern DF, Edgerton SM, Whalen SG, Moore D, Thor AD: Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients. J Clin Oncol 2005; 23:1152-1160. (Pubitemid 46202271)
9. Swinson DE, Cox G, O'Byrne KJ: Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer. Br J Cancer 2004; 91:1301-1307. (Pubitemid 39424791)
10. Di Lorenzo G, Tortora G, D'Armiento FP, De Rosa G, Staibano S, Autorino R, D'Armiento M, De Laurentiis M, De Placido S, Catalano G, Bianco AR, Ciardiello F: Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin Cancer Res 2002; 8:3438-3444. (Pubitemid 35340719)
11. Hanawa M, Suzuki S, Dobashi Y, Yamane T, Kono K, Enomoto N, Ooi A: EGFR protein over-expression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer 2006; 118:1173-1180. (Pubitemid 43185604)
12. Zhang GY, Zhang Q, Zhang QX, Yin L, Li SL, Cheng KS, Zhang YH, Xu HH, Wu WD: Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues. J Cancer Res Clin 2010; 136:587-594.
13. Wei QC, Chen LR, Sheng LM, Nordgren H, Wester K, Carlsson J: EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases. Int J Oncol 2007; 31:493-499.
14. Parmar MKB, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17:2815-2834. (Pubitemid 28562978)
15. Lau J, Ioannidis JP, Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127:820-826.
16. DerSimonian R, Laird N: Metaanalysis in clinical-trials. Control Clin Trials 1986; 7:177-188.
17. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50:1088-1101.
18. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. Brit Med J 1997; 315:629-634. (Pubitemid 27387172)
19. Fukai Y, Masuda N, Kato H, Fukuchi M, Miyazaki T, Nakajima M, Sohda M, Kuwano H, Nakajima T: Correlation between laminin-5 gamma(2) chain and epidermal growth factor receptor expression in esophageal squamous cell carcinomas. Oncology 2005; 69:71-80.
20. Inada S, Koto T, Futami K, Arima S, Iwashita A: Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). Surg Today 1999; 29:493-503. (Pubitemid 29313958)
21. Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S, Nagura H: Epidermal growth factor receptor over-expression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 1994; 74:795-804.
22. Iihara K, Shiozaki H, Tahara H, Kobayashi K, Inoue M, Tamura S, Miyata M, Oka H, Doki Y, Mori T: Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation. Cancer 1993; 71:2902-2909. (Pubitemid 23145515)
23. Yano H, Shiozaki H, Kobayashi K, Yano T, Tahara H, Tamura S, Mori T: Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma. Cancer 1991; 67:91-98.
24. Delektorskaya VV, Chemeris GY, Kononets PV, Grigorchuk AY: Clinical Significance of Hyperexpression of Epidermal Growth Factor Receptors (EGFR and HER-2) in Esophageal Squamous Cell Carcinoma. B Exp Biol Med 2009; 148:241-245.
25. Sunpaweravong P, Sunpaweravong S, Puttawibul P, Mitarnun W, Zeng C, Baron AE, Franklin W, Said S, Varella-Garcia M: Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous celi carcinoma. J Cancer Res Clin 2005; 131:111-119. (Pubitemid 40192936)
26. Gibault L, Metges JP, Conan-Charlet V, Lozac'h P, Robaszkiewicz M, Bessaguet C, Lagarde N, Volant A: Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer. Brit J Cancer 2005; 93:107-115. (Pubitemid 41076258)
27. Torzewski M, Sarbia M, Verreet P, Bittinger F, Dutkowski P, Heep H, Willers R, Gabbert HE: The prognostic significance of epidermal growth factor receptor expression in squamous cell carcinomas of the oesophagus. Anticancer Res 1997; 17:3915-3919. (Pubitemid 28014961)
28. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD: Close Similarity of Epidermal Growth-Factor Receptor and V-Erb-B Oncogene Protein Sequences. Nature 1984; 307:521-527.
29. Lin CR, Chen WS, Kruiger W, Stolarsky LS, Weber W, Evans RM, Verma IM, Gill GN, Rosenfeld MG: Expression Cloning of Human Egf Receptor Complementary-DNA-Gene Amplification and 3 Related Messenger-Rna Products in A431-Cells. Science 1984; 224:843-848. (Pubitemid 14102458)
30. Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hoelscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJB, Wong J, DeMeester TR: The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: An International Study on the Impact of Extent of Surgical Resection. Ann Surg 2008; 248:549-556.
31. Mariette C, Piessen G, Briez N, Triboulet JP: The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 2008; 247:365-371. (Pubitemid 351156783)
32. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K: Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis. Thorax 2006; 61: 140-145. (Pubitemid 43235431)
33. Meert AP, Martin B, Delmotte P, Berghmans T, Lafitte JJ, Mascaux C, Paesmans M, Steels E, Verdebout JM, Sculier JP: The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J 2002; 20: 975-981.
34. Pham B, Klassen TP, Lawson ML, Moher D: Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary. J Clin Epidemiol 2005; 58:769-776. (Pubitemid 40966834)